- How do you continue to collect data and preserve your study?
- Considerations for your endpoints; are your outcome measures still valid if you go remote?
- What is the impact on interpretation of outcomes; can you combine pre-event and post-event data and baselines?
Most Recent Flipbooks
In a recent webinar, Steven Beales, Senior VP, Scientific and Regulatory at WCG, facilitated a conversation with FDA leaders, discussing overreporting SUSARs and the impact on patient safety.
16 industry experts share shifts and trends that will inform clinical research in 2020 and beyond.